0001104659-23-125434.txt : 20231212
0001104659-23-125434.hdr.sgml : 20231212
20231212173022
ACCESSION NUMBER: 0001104659-23-125434
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231208
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Steven Clive
CENTRAL INDEX KEY: 0001883325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40825
FILM NUMBER: 231482194
MAIL ADDRESS:
STREET 1: C/O WARBY PARKER INC.
STREET 2: 233 SPRING STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Warby Parker Inc.
CENTRAL INDEX KEY: 0001504776
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 800423634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 847-7215
MAIL ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: JAND, Inc.
DATE OF NAME CHANGE: 20101102
4
1
tm2332712-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-08
0
0001504776
Warby Parker Inc.
WRBY
0001883325
Miller Steven Clive
C/O WARBY PARKER INC.,
233 SPRING STREET, 6TH FLOOR EAST
NEW YORK
NY
10013
0
1
0
0
Chief Financial Officer
1
Class A Common Stock
2023-12-08
4
M
0
18480
0
A
207064
D
Class A Common Stock
2023-12-08
4
S
0
7760
10.56
D
199304
D
Class A Common Stock
2023-12-11
4
S
0
21550
11.42
D
177754
D
Restricted Stock Units
2023-12-08
4
M
0
1981
0
D
Class A Common Stock
1981
9245
D
Restricted Stock Units
2023-12-08
4
M
0
2525
0
D
Class A Common Stock
2525
1684
D
Restricted Stock Units
2023-12-08
4
M
0
5095
0
D
Class A Common Stock
5095
33973
D
Restricted Stock Units
2023-12-08
4
M
0
8879
0
D
Class A Common Stock
8879
112477
D
Includes 1,332 shares acquired on May 14, 2023 under the Issuer's employee stock purchase plan in an exempt transaction pursuant to Rule 16b-3(c).
These share sales are required by the Issuer's equity compensation plan to cover taxes due on restricted stock units ("RSUs") that vested.
These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2023.
The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $10.52 to $11.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.
This filing relates to the occurrence of a RSU vesting event.
The RSUs will vest in 48 monthly installments beginning on January 1, 2021.
The RSUs will vest in 48 monthly installments beginning on January 1, 2020.
The RSUs will vest in 48 monthly installments beginning on July 1, 2021.
The RSUs will vest in 48 substantially equal monthly installments beginning on February 3, 2023.
/s/ Chris Utecht, Attorney-in-Fact
2023-12-12